Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03304327 · ClinicalTrials.gov registry record · NA
Mindfulness and Yoga Training for Athletes With Concussion (MYTAC)
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT03304327: Completed NA study, sponsored by Duke University.
NCT03304327 is a NA study that has completed, run by Duke University. The registered enrollment target is 16 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03304327, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
The purpose of this study is to establish the tolerability of mindfulness and yoga therapy in the post-concussion period.
Interventions
- BEHAVIORAL Mindfulness and Yoga Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2017-09-27 |
| Est. Completion | 2019-09-23 |
| Phase | NA |
What the finished NCT03304327 record still lists
NCT03304327 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Mindfulness and Yoga Training is the first listed.
NCT03304327 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03304327 about?
NCT03304327 is a clinical study titled "Mindfulness and Yoga Training for Athletes With Concussion (MYTAC)". The purpose of this study is to establish the tolerability of mindfulness and yoga therapy in the post-concussion period.
What is the current status of trial NCT03304327?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2017-09-27. Estimated completion is 2019-09-23.
What interventions are being tested in trial NCT03304327?
The interventions under investigation include: Mindfulness and Yoga Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT03304327?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03304327's enrollment target sits among peer trials
16 1871st of 2000 higher than 120 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI